Pharmafile Logo

long-term condition

- PMLiVE

Stelara outlook promising for psoriatic arthritis

Likely to be recommended alone and in combination with methotrexate

National Institute for Health and Care Excellence NICE logo

NICE system ‘slowing market access to cancer meds’

Two new reports show that UK access to new treatments and survival rates among lowest in Europe

- PMLiVE

Axon Communications boosts London team with five hires

Lucie Burns, Denis Bilotta, Samantha Treadwell, Karley Ura, Kate Peregrin all new-comers

ABPI London offices

Industry pays £310m to underwrite medicines bills

Latest fourth quarter rebate revealed as pharma looks to ‘underwrite’ the NHS drugs bill

UK flag

Cancer Drugs Fund a ‘missed opportunity’, says MP

Chair of the Liberal Democrat health committee Paul Burstow says the CDF should have gone further

- PMLiVE

UCB plans epilepsy ‘hackathon’ to develop new digital tools

Aims to attract developers, designers and digital experts to Hack Epilepsy

- PMLiVE

Cosentyx has big impact on psoriasis, says Novartis

New data shows it to achieve clear or almost clear skin

- PMLiVE

GSK sells another chunk of South Africa’s Aspen

Paid $418m for an 18% share in Aspen in 2009

Webinar on-demand: The e-detailing wow factor in 2015

E-detailing and closed loop marketing is too often seen as a technical issue rather than a creative one. Yet to get the most from the technology you need to have...

Anthill Agency

- PMLiVE

Maetrics promotes Steve Cottrell to president

Was previously VP of business development

- PMLiVE

Takeda’s Entyvio recommended by NICE for bowel disease

But must supply the drug at a discounted rate to the NHS

Use of biomarkers in marketing

Mark Assenti talks about utilisation of biomarkers in marketing is a trend that we have seen growing in 2014 and expect to hear even more about into 2015.

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links